Amy F. Lerman is a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office of Epstein Becker Green. Ms. Lerman focuses her practice on a variety of regulatory and transactional health care matters, including telehealth and telemedicine, government investigations, corporate compliance, durable medical equipment, and Medicare program integrity auditing and monitoring. She represents a variety of health care providers and organizations, as well as investors and other financial institutions that invest in or support the health care industry.

Ms. Lerman’s experience advising clients on regulatory considerations related to telehealth, telemedicine, and other mobile health and health technology issues includes:

  • Advising clients on regulatory compliance, reimbursement, coverage, and policy issues related to the use of telehealth, telemedicine, mobile health, and related health technology platforms
  • Counseling clients on compliance with state and federal laws affecting provision of telehealth and telemedicine services, including issues related to practice of medicine/scope of practice, licensure, online prescribing, reimbursement and coverage, privacy and security, and risk management
  • Assisting clients with regard to the regulatory issues in establishing regional and national telemedicine networks

In addition, Ms. Lerman co-authored the firm’s Telemental Health Laws app, a comprehensive survey of state telehealth laws, regulations, and policies for mental and behavioral health practitioners and stakeholders across all 50 states and the District of Columbia. The 2018 data is an update to the firm’s original 50-State Survey of Telemental/Telebehavioral Health (2016) and its 2017 Appendix, both co-authored by Ms. Lerman.

Read Amy’s full biography.